Shares of Vincerx Pharma saw volatile trading on Wednesday, swinging between gains and losses after the company unveiled ...

Cost Plus Drugs CEO Alex Oshmyansky TK on the latest episode of the “Rapid Response” podcast.

Revolution has set itself a mission to revolutionize treatment for patients with RAS addicted cancers. See why I upgrade RVMD ...

Pharma giant GSK is buying into Rgenta Therapeutics’ mission to develop a pipeline of oral RNA-targeting small molecules. | ...

Some of the world's largest hedge funds are hiring doctors, scientists and analysts to give them expert insight into the ...

Artificial intelligence (AI) is changing the way companies do business -- helping programmers write code and fielding ...

BMS has been among the pharma giants that have bought into AI for drug discovery. In 2021, the company struck a $1.2 billion ...

Despite billions poured into research, new medicines still typically take a decade or more to develop.

Discover how Trump’s healthcare picks could reshape U.S. biopharma and drive major changes in the healthcare policy.

While antiviral drugs to treat HIV had been approved a decade earlier, only five out of 33 million people who carried the ...

Few companies garner as much reliable attention as Novo Nordisk (NYSE: NVO) does these days. Novo Nordisk is among the fastest-growing big pharma competitors, which makes it easy to formulate a long ...